scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PNAS..10912105X |
P356 | DOI | 10.1073/PNAS.1120914109 |
P932 | PMC publication ID | 3409739 |
P698 | PubMed publication ID | 22773818 |
P5875 | ResearchGate publication ID | 228447290 |
P50 | author | Johanna M Sweere | Q57062054 |
Raymond A Sobel | Q87841746 | ||
Vijay Kuchroo | Q87889159 | ||
Francisco J. Quintana | Q88364866 | ||
Chuan Wu | Q57017609 | ||
P2093 | author name string | Sheng Xiao | |
Ada Yeste | |||
Joseph V Bonventre | |||
Takaharu Ichimura | |||
Chen Zhu | |||
Craig R Brooks | |||
Sonia Petecka | |||
P2860 | cites work | Immunosuppressive effects of apoptotic cells | Q59060221 |
Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10 | Q80785928 | ||
The Cys-rich region of hepatitis A virus cellular receptor 1 is required for binding of hepatitis A virus and protective monoclonal antibody 190/4 | Q24523091 | ||
The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor | Q24523454 | ||
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. | Q24657708 | ||
Structures of T Cell Immunoglobulin Mucin Protein 4 Show a Metal-Ion-Dependent Ligand Binding Site where Phosphatidylserine Binds | Q27649330 | ||
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family | Q28207890 | ||
Immunology: hepatitis A virus link to atopic disease | Q28208230 | ||
TIM-1 induces T cell activation and inhibits the development of peripheral tolerance | Q28241921 | ||
TIM-1, a novel allergy and asthma susceptibility gene | Q28249050 | ||
Regulation of tolerance in the respiratory tract: TIM-1, hygiene, and the environment | Q28305029 | ||
Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells | Q28573345 | ||
TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury | Q28591447 | ||
Tim-2 regulates T helper type 2 responses and autoimmunity | Q33220331 | ||
Identification of Tim4 as a phosphatidylserine receptor | Q33303850 | ||
Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice | Q34080154 | ||
TIM-4 expressed on APCs induces T cell expansion and survival | Q34170292 | ||
Regulatory T cells and Foxp3 | Q34177949 | ||
Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans | Q34627078 | ||
Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys | Q34892862 | ||
Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells | Q35084636 | ||
The TIM gene family: emerging roles in immunity and disease | Q35140798 | ||
Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice | Q35187089 | ||
Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions | Q35218397 | ||
Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells | Q35956837 | ||
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function | Q36229490 | ||
TIM family of genes in immunity and tolerance | Q36580104 | ||
The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals | Q37069155 | ||
Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity | Q37072801 | ||
TIM gene family and their role in atopic diseases | Q37252316 | ||
Regulatory B cells as inhibitors of immune responses and inflammation | Q37256986 | ||
Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells | Q37366061 | ||
TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity | Q37763998 | ||
Novel roles for TIM-1 in immunity and infection | Q37930745 | ||
Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response. | Q39867601 | ||
Tim1 and Tim3 are not essential for experimental allergic asthma | Q42097415 | ||
New roles for TIM family members in immune regulation | Q44470505 | ||
TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. | Q51818425 | ||
P433 | issue | 30 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell function | Q95674809 |
P304 | page(s) | 12105-12110 | |
P577 | publication date | 2012-07-05 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice | |
P478 | volume | 109 |
Q57976581 | A splenic IgM memory subset with antibacterial specificities is sustained from persistent mucosal responses |
Q35235319 | Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis |
Q101038988 | Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease |
Q41003256 | Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice |
Q64279721 | Association of interleukin-27 gene polymorphisms with susceptibility to HIV infection and disease progression |
Q90599409 | Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles |
Q39345723 | CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients |
Q89908654 | CD19+CD24hiCD38hi B Cell Dysfunction in Primary Biliary Cholangitis |
Q47639693 | CD27+TIM-1+ memory B cells promoted the development of Foxp3+ Tregs and were associated with better survival in acute respiratory distress syndrome |
Q30409350 | Characterizing functional domains for TIM-mediated enveloped virus entry |
Q37128891 | Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. |
Q28397407 | Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity |
Q38170793 | Contributions of B cells to lupus pathogenesis |
Q55019070 | Decreased Breg/Th17 Ratio Improved the Prognosis of Patients with Ulcerative Colitis. |
Q34004649 | Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupus |
Q42231946 | Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Fas(lpr) mice |
Q38742256 | Expression of Tim-1 in primary CNS lymphoma |
Q90019854 | Follicular cytotoxic CD8 T cells present high cytokine expression, and are more susceptible to Breg-mediated suppression in non-small cell lung cancer |
Q49318689 | Galectin-1 is required for the regulatory function of B cells. |
Q34138195 | Generation and identification of tumor-evoked regulatory B cells |
Q35106912 | IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses. |
Q40184422 | IL-21/anti-Tim1/CD40 ligand promotes B10 activity in vitro and alleviates bone loss in experimental periodontitis in vivo |
Q26740298 | Immune Regulation and Antitumor Effect of TIM-1 |
Q49805205 | Immune Tolerance to Apoptotic Self Is Mediated Primarily by Regulatory B1a Cells. |
Q39215639 | Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis |
Q35849866 | Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy |
Q33793070 | Insulin-like growth factor-2 enhances functions of antigen (Ag)-specific regulatory B cells |
Q53327428 | Introduction: Regulatory B Cell Special Issue-making all the pieces fit. |
Q36148385 | KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation |
Q35409103 | KIM-1-mediated phagocytosis reduces acute injury to the kidney |
Q42923626 | KIM-1/TIM-1 in proximal tubular cell immune response |
Q100387986 | KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and Kidney |
Q90329271 | Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies |
Q51758759 | Meis1 is specifically upregulated in kidney myofibroblasts during aging and injury but is not required for kidney homeostasis or fibrotic response. |
Q59326875 | Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy |
Q91012553 | MicroRNA-146a-deficient mice develop immune complex glomerulonephritis |
Q38636569 | Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy |
Q36011177 | New insights into B cell biology in systemic lupus erythematosus and Sjögren's syndrome |
Q27015034 | Phosphatidylserine receptors: enhancers of enveloped virus entry and infection |
Q39084950 | Potential importance of B cells in aging and aging-associated neurodegenerative diseases |
Q42276429 | Reduced numbers of regulatory B cells are negatively correlated with disease activity in patients with new-onset rheumatoid arthritis |
Q39160359 | Regulatory B cells: Phenotype, function and role in transplantation |
Q38233691 | Regulatory functions of B cells in allergic diseases |
Q35979565 | Renal Transplant Recipients Treated with Calcineurin-Inhibitors Lack Circulating Immature Transitional CD19+CD24hiCD38hi Regulatory B-Lymphocytes |
Q35726920 | Retracted: Regulatory B Cell Function Is Suppressed by Smoking and Obesity in H. pylori-Infected Subjects and Is Correlated with Elevated Risk of Gastric Cancer |
Q26824451 | Role of B cells in tolerance induction |
Q38468652 | Signals controlling the development and activity of regulatory B-lineage cells |
Q37067433 | T-cell immunoglobulin and mucin domain 1 deficiency eliminates airway hyperreactivity triggered by the recognition of airway cell death |
Q40412394 | TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. |
Q37595691 | TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients |
Q33788812 | TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity |
Q27314979 | TIM-1 signaling is required for maintenance and induction of regulatory B cells |
Q26753825 | The clearance of dying cells: table for two |
Q38526835 | The expanding family of regulatory B cells. |
Q35137217 | Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation |
Q57177957 | Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management |
Q40273988 | What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis? |
Q48578964 | miR-21 silencing ameliorates experimental autoimmune encephalomyelitis by promoting the differentiation of IL-10-producing B cells |
Search more.